Influence of Thoracic Paravertebral Block on Atrioventricular Conduction

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 20, 2025

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Conduction AbnormalitiesParavertebral Anesthesia
Interventions
PROCEDURE

Paravertebral block (ropivacaine) left

Paravertebral block at the level of 3rd thoracic intervertebral space on the left side. 0.5% Ropivacaine 0.3 ml·kg-1, not exceeding 30 ml, based on ideal body weight in obese patients

PROCEDURE

Paravertebral block (ropivacaine) right

Paravertebral block at the level of 3rd thoracic intervertebral space on the right side. 0.5% Ropivacaine 0.3 ml·kg-1, not exceeding 30 ml, based on ideal body weight in obese patients

Trial Locations (1)

Unknown

Gdański Uniwersytet Medyczny, Gdansk

All Listed Sponsors
lead

Medical University of Gdansk

OTHER

NCT06833086 - Influence of Thoracic Paravertebral Block on Atrioventricular Conduction | Biotech Hunter | Biotech Hunter